Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1521 of 6351
-
Which fluid works best for severe diabetic ketoacidosis? a new trial aims to find out
Disease control Recruiting nowManagement of severe diabetic ketoacidosis is based on insulin therapy, correction of metabolic disorders and fluid resuscitation. Current recommendations recommend the first-line use of isotonic saline, whose composition is unbalanced, rich in chloride and sodium compared with p…
Phase 4 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New shot aims to tame bleeding disorder in small trial
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, pharmacokinetics (PK), and pharmacodynamic (PD) of SR604 in patients with von Willebrand disease.
Phase 2 • Sponsor: Shanghai RAAS Blood Products Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Videogame 'ACTing Minds' tested as quick mental health boost
Symptom relief CompletedThe goal of this clinical trial is to test whether a single-session Acceptance and Commitment Therapy (ACT) videogame (ACTing Minds) improves psychological flexibility and mental health in adults who report mild to moderate depression, anxiety or stress. The main questions are wh…
Sponsor: Swansea University • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New hope for myasthenia crisis: early ravulizumab may speed ICU recovery
Disease control Recruiting nowMyasthenia Gravis (MG) is a rare autoimmune disease that causes muscle weakness and fatigue. It occurs when the immune system produces antibodies that block communication between nerves and muscles. In some patients, the disease can suddenly worsen and cause severe breathing prob…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New targeted drug trial opens for patients with Hard-to-Treat neuroendocrine cancers
Disease control Recruiting nowThis Phase 1/2, multicenter, open-label, FIH study aims to evaluate the safety, tolerability, PK, and preliminary antitumor activity of CRN09682 in participants with SST2-expressing NENs and other solid tumors. The study includes a Dose Escalation Phase to determine the MTD and D…
Phase 1/2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New pacing technique may improve outcomes after heart valve procedure
Disease control Recruiting nowTranscatheter aortic valve implantation (TAVI) has rapidly expanded over the past decade as a treatment for severe aortic valve stenosis, with over 14,000 procedures performed in France in 2021. A common complication following TAVI is traumatic atrioventricular block requiring pa…
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Immune cell therapy takes on stubborn muscle weakness
Disease control Not yet recruitingThis study is a single-center, prospective, nonrandom, single-arm trial.
Early phase 1 • Sponsor: Guangdong ProCapZoom Biosciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Acupuncture with electricity may help men stop leaking after prostate removal
Symptom relief Not yet recruitingThis clinical trial aims to find out if early electroacupuncture (EA) helps people recover the ability to control urination and is safe after surgery to remove the prostate gland for prostate cancer (radical prostatectomy). Participants are people aged 18 to 80 with localized pr…
Sponsor: Shanghai University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Nerve zaps plus hand training could boost stroke recovery
Symptom relief Recruiting nowStroke is a leading cause of death and disability worldwide, resulting in significant physical and cognitive impairments. Arm weakness is most common after stroke and its treatment is recognized as an area of considerable need. The functional limitations and disabilities experien…
Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New hope for chronic hives: barzolvolimab shows promise in Long-Term trial
Disease control By invitation onlyThe purpose of this extension study is to collect long-term efficacy and safety data on barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) who completed the treatment and follow-up periods of the Phase 3 clinical trials. This study will also fulfill the…
Phase 3 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Digital twin tech could predict aortic rupture risk
Knowledge-focused Recruiting nowAortic dissection causes a tear in the inner layers of the aorta, leading to the formation of a true and false lumen. There are two types of dissection: type A, which affects the ascending aorta, and type B, which affects the descending aorta. Type A aortic dissection is almost …
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Blood test may let some cancer patients skip extra immunotherapy
Disease control Recruiting nowThe researchers are doing this study to evaluate the use of circulating tumor DNA (ctDNA) testing in making treatment decisions for advanced/recurrent endometrial cancer that has a change (mutation) in the mismatch repair deficient (MMR-D) gene or microsatellite instability high …
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can mindfulness ease serious mental illness? new study aims to find out
Symptom relief By invitation onlySerious mental illness (SMI), encompassing schizophrenia-spectrum and major mood disorders, has been estimated to affect approximately 5.4% of the U.S. adult population each year. Research shows low rates of evidence-based treatment being provided to patients with SMI. This is un…
Sponsor: Butler Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Can a minty mouth rinse boost explosive power?
Symptom relief CompletedMenthol activates the transient receptor potential melastatin 8 (TRPM8) channel and can alter thermal and respiratory perception without producing an actual reduction in body or tissue temperature. Evidence on whether oral menthol improves short-duration maximal (anaerobic) perfo…
Sponsor: Vedat Cinar • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Can Hands-On therapy unknot stubborn neck tension?
Symptom relief CompletedThe primary purpose of this study is to investigate and compare the effects of different physiotherapy approaches, such as manipulation, mobilization, and neck exercises, on pain, range of motion, neck functionality, quality of life, muscle tightness, and psychological status in …
Sponsor: Istanbul Rumeli University • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can light and sound replace X-Rays? a new imaging method aims to see inside without radiation
Knowledge-focused Recruiting nowIn medical imaging, X-ray-based methods are widely used, which means that patients are exposed to ionizing radiation. In addition, invasive tissue samples often need to be taken with biopsy needles to, for example, safely determine or rule out a cancer diagnosis. With this projec…
Sponsor: Lund University • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Heart bypass patients: which blood thinner works best to keep grafts open?
Disease control Recruiting nowThe purpose of this study is to compare the effect of prasugrel plus low-dose aspirin versus high dose aspirin alone (300mg) and versus low dose aspirin alone (75 mg) in patients with chronic coronary disease undergoing coronary artery bypass grafting.
Phase 3 • Sponsor: Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
One pill to beat worms? new drug emodepside takes on mebendazole
Disease control OngoingThis study aims to assess the efficacy and safety of emodepside compared to mebendazole in adults and adolescents infected with T. trichiura, either as single infection or co-infections with hookworm and/or A. lumbricoides.
Phase 3 • Sponsor: Swiss Tropical & Public Health Institute • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can an asthma drug slow ALS? new trial aims to find out
Disease control Recruiting nowThe purpose of this study is to test the effects of PHENOGENE-1A, which is the treatment under investigation in this study. This research will investigate if PHENOGENE-1A can help people with ALS by measuring their function using the ALS Functional Rating Scale Revised (ALSFRS-R)…
Phase 2 • Sponsor: PhenoNet, Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New hope for Hard-to-Treat cancers: experimental drug BMS-986523 enters human trials
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, and efficacy of BMS-986523 alone and in combination with anti-cancer agents in participants with advanced solid malignancies
Phase 1/2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC